KMT2A and acute lymphoblastic leukemia: There are likely to be distinct, MLL-AF4-independent mechanisms maintaining these enhancers in non-MLLr ALL, and it is also possible that MLL-AF4 is not the main driver of enhancer activity at these loci in MLL-AF4 leukemia.